Cargando…
Molecular Characterization and Putative Pathogenic Pathways of Tuberous Sclerosis Complex–Associated Renal Cell Carcinoma
Tuberous sclerosis complex–associated renal cell carcinoma (TSC-RCC) has distinct clinical and histopathologic features and is considered a specific subtype of RCC. The genetic alterations of TSC1 or TSC2 are responsible for the development of TSC. In this study, we assessed the mTOR pathway activat...
Autores principales: | Park, Jeong Hwan, Lee, Cheol, Chang, Mee Soo, Kim, Kwangsoo, Choi, Seongmin, Lee, Hyunjung, Lee, Hyun-Seob, Moon, Kyung Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008483/ https://www.ncbi.nlm.nih.gov/pubmed/29925043 http://dx.doi.org/10.1016/j.tranon.2018.05.010 |
Ejemplares similares
-
Renal Cell Carcinoma in Tuberous Sclerosis Complex
por: Henske, Elizabeth P., et al.
Publicado: (2021) -
Two Different Renal Cell Carcinomas and Multiple Angiomyolipomas in a Patient with Tuberous Sclerosis
por: Kang, Sung Gu, et al.
Publicado: (2010) -
Renal Manifestations of Tuberous Sclerosis Complex
por: Nair, Nikhil, et al.
Publicado: (2020) -
Ketogenic Diet for the Management of Epilepsy Associated with Tuberous Sclerosis Complex in Children
por: Park, Soyoung, et al.
Publicado: (2017) -
The Putative Role of mTOR Inhibitors in Non-tuberous Sclerosis Complex-Related Epilepsy
por: Goldstein, Hannah E., et al.
Publicado: (2021)